Literature DB >> 29650794

Comprehensive analysis of the mutation spectrum in 301 German ALS families.

Kathrin Müller1, David Brenner1, Patrick Weydt1,2, Thomas Meyer3, Torsten Grehl4, Susanne Petri5, Julian Grosskreutz6, Joachim Schuster1, Alexander E Volk7,8, Guntram Borck7, Christian Kubisch7,8, Thomas Klopstock9,10, Daniel Zeller11, Sibylle Jablonka12, Michael Sendtner12, Stephan Klebe11,13, Antje Knehr1, Kornelia Günther1, Joachim Weis14, Kristl G Claeys14,15,16,17, Berthold Schrank18, Anne-Dorte Sperfeld19, Annemarie Hübers1, Markus Otto1, Johannes Dorst1, Thomas Meitinger20,21,22, Tim M Strom20,21,22, Peter M Andersen1,23, Albert C Ludolph1, Jochen H Weishaupt1.   

Abstract

OBJECTIVES: Recent advances in amyotrophic lateral sclerosis (ALS) genetics have revealed that mutations in any of more than 25 genes can cause ALS, mostly as an autosomal-dominant Mendelian trait. Detailed knowledge about the genetic architecture of ALS in a specific population will be important for genetic counselling but also for genotype-specific therapeutic interventions.
METHODS: Here we combined fragment length analysis, repeat-primed PCR, Southern blotting, Sanger sequencing and whole exome sequencing to obtain a comprehensive profile of genetic variants in ALS disease genes in 301 German pedigrees with familial ALS. We report C9orf72 mutations as well as variants in consensus splice sites and non-synonymous variants in protein-coding regions of ALS genes. We furthermore estimate their pathogenicity by taking into account type and frequency of the respective variant as well as segregation within the families.
RESULTS: 49% of our German ALS families carried a likely pathogenic variant in at least one of the earlier identified ALS genes. In 45% of the ALS families, likely pathogenic variants were detected in C9orf72, SOD1, FUS, TARDBP or TBK1, whereas the relative contribution of the other ALS genes in this familial ALS cohort was 4%. We identified several previously unreported rare variants and demonstrated the absence of likely pathogenic variants in some of the recently described ALS disease genes.
CONCLUSIONS: We here present a comprehensive genetic characterisation of German familial ALS. The present findings are of importance for genetic counselling in clinical practice, for molecular research and for the design of diagnostic gene panels or genotype-specific therapeutic interventions in Europe. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  amyotrophic lateral sclerosis; genetics; whole exome sequencing

Mesh:

Substances:

Year:  2018        PMID: 29650794     DOI: 10.1136/jnnp-2017-317611

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  How much of the missing heritability of ALS is hidden in known ALS genes?

Authors:  Philip Van Damme
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-04-12       Impact factor: 10.154

2.  Searching for Bacteria in Neural Tissue From Amyotrophic Lateral Sclerosis.

Authors:  Ruth Alonso; Diana Pisa; Luis Carrasco
Journal:  Front Neurosci       Date:  2019-02-26       Impact factor: 4.677

3.  Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis.

Authors:  Marcel Naumann; Kevin Peikert; Rene Günther; Anneke J van der Kooi; Eleonora Aronica; Annemarie Hübers; Veronique Danel; Philippe Corcia; Francisco Pan-Montojo; Sebahattin Cirak; Göknur Haliloglu; Albert C Ludolph; Anand Goswami; Peter M Andersen; Johannes Prudlo; Florian Wegner; Philip Van Damme; Jochen H Weishaupt; Andreas Hermann
Journal:  Ann Clin Transl Neurol       Date:  2019-11-04       Impact factor: 4.511

4.  Sorting Rare ALS Genetic Variants by Targeted Re-Sequencing Panel in Italian Patients: OPTN, VCP, and SQSTM1 Variants Account for 3% of Rare Genetic Forms.

Authors:  Viviana Pensato; Stefania Magri; Eleonora Dalla Bella; Pierpaola Tannorella; Enrica Bersano; Gianni Sorarù; Marta Gatti; Nicola Ticozzi; Franco Taroni; Giuseppe Lauria; Caterina Mariotti; Cinzia Gellera
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

Review 5.  Gene specific therapies - the next therapeutic milestone in neurology.

Authors:  David Brenner; Albert C Ludolph; Jochen H Weishaupt
Journal:  Neurol Res Pract       Date:  2020-09-08

6.  Case Report: Cognitive Conversion in a Non-brazilian VAPB Mutation Carrier (ALS8).

Authors:  Anna G M Temp; Martin Dyrba; Elisabeth Kasper; Stefan Teipel; Johannes Prudlo
Journal:  Front Neurol       Date:  2021-06-02       Impact factor: 4.003

Review 7.  Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Authors:  Ramya Ranganathan; Shaila Haque; Kayesha Coley; Stephanie Shepheard; Johnathan Cooper-Knock; Janine Kirby
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

8.  Novel mutation in optineurin causing aggressive ALS+/-frontotemporal dementia.

Authors:  Shu-Man Feng; Chun-Hui Che; Shu-Yan Feng; Chang-Yun Liu; Liu-Yi Li; Yuan-Xiao Li; Hua-Pin Huang; Zhang-Yu Zou
Journal:  Ann Clin Transl Neurol       Date:  2019-12-15       Impact factor: 4.511

9.  Novel and Recurrent Mutations in a Cohort of Chinese Patients With Young-Onset Amyotrophic Lateral Sclerosis.

Authors:  Jianwen Deng; Wei Wu; Zhiying Xie; Qiang Gang; Meng Yu; Jing Liu; Qingqing Wang; He Lv; Wei Zhang; Yining Huang; Tao Wang; Yun Yuan; Daojun Hong; Zhaoxia Wang
Journal:  Front Neurosci       Date:  2019-12-06       Impact factor: 4.677

10.  Cognitive Profiles of Amyotrophic Lateral Sclerosis Differ in Resting-State Functional Connectivity: An fMRI Study.

Authors:  Anna G M Temp; Martin Dyrba; Charlotte Büttner; Elisabeth Kasper; Judith Machts; Jörn Kaufmann; Stefan Vielhaber; Stefan Teipel; Johannes Prudlo
Journal:  Front Neurosci       Date:  2021-06-23       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.